Advertisement
Advertisement
KROS
Keros Therapeutics, Inc. Common Stock
11.62
USDSponsored
+0.07
+0.61%
Sep 25, 15:59 UTC -4
Closed
After-Market
11.63
+0.01
+0.04%
Keros Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 230.49M |
| Beta | 1.01 |
| Earnings Per Share (EPS) | -3.70 |
| Price-to-Book (P/B) Ratio | 0.87 |
| Operating Margin | -256.60% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -21.40% |
| Current Ratio | 21.96% |
| Free Cash Flow | -24.18M |
